Recent studies also reported the possibilities of autoantibodies, microRNAs and circulating tumor DNA in the blood or fluid from the cervix, uterus or the fallopian tube that could augment the early diagnosis of ovarian cancer in addition to detection of CA125 biomarker (Elias et al., 2018). Here, MUC16 is linked to ovarian cancer.